Skip to content
10-Q

Quarterly Report

Dianthus Therapeutics, Inc. DNTH

0000950170-25-105030

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 32.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 35.82M sh
Shares Diluted Q2 2025 · Jun 30, 2025 35.81M sh
Shares Diluted Q2 2025 · Jun 30, 2024 34.23M sh
Shares Diluted Q2 2025 · Jun 30, 2024 31.79M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$51.52M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$29.47M
Short Term Investments Q2 2025 · Jun 30, 2025 $244.15M
Short Term Investments Q2 2025 · Dec 31, 2024 $252.45M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $13.24M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $22.79M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $314.17M
Stockholders Equity Q2 2025 · Jun 30, 2025 $303.08M
Stockholders Equity Q2 2025 · Mar 31, 2025 $328.61M
Stockholders Equity Q2 2025 · Dec 31, 2024 $352.48M
Stockholders Equity Q2 2025 · Jun 30, 2024 $358.22M
Stockholders Equity Q2 2025 · Mar 31, 2024 $372.69M
Stockholders Equity Q2 2025 · Dec 31, 2023 $168.87M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.09M
Current Liabilities Q2 2025 · Dec 31, 2024 $18.45M
Total Liabilities Q2 2025 · Jun 30, 2025 $23M
Total Liabilities Q2 2025 · Dec 31, 2024 $21.53M
Current Assets Q2 2025 · Jun 30, 2025 $263.61M
Current Assets Q2 2025 · Dec 31, 2024 $280.9M
Total Assets Q2 2025 · Jun 30, 2025 $326.08M
Total Assets Q2 2025 · Dec 31, 2024 $374.01M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.88
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.71
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.51
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.99
Eps Basic Q2 2025 · Jun 30, 2025 −$0.88
Eps Basic Q2 2025 · Jun 30, 2025 −$1.71
Eps Basic Q2 2025 · Jun 30, 2024 −$0.51
Eps Basic Q2 2025 · Jun 30, 2024 −$0.99
Sga Expense Q2 2025 · Jun 30, 2025 $8.87M
Sga Expense Q2 2025 · Jun 30, 2025 $16.21M
Sga Expense Q2 2025 · Jun 30, 2024 $6M
Sga Expense Q2 2025 · Jun 30, 2024 $11.64M
Rd Expense Q2 2025 · Jun 30, 2025 $26.25M
Rd Expense Q2 2025 · Jun 30, 2025 $53.25M
Rd Expense Q2 2025 · Jun 30, 2024 $18.07M
Rd Expense Q2 2025 · Jun 30, 2024 $31.15M
Net Income Q2 2025 · Jun 30, 2025 −$31.63M
Net Income Q2 2025 · Jun 30, 2025 −$61.14M
Net Income Q2 2025 · Mar 31, 2025 −$29.51M
Net Income Q2 2025 · Jun 30, 2024 −$17.61M
Net Income Q2 2025 · Jun 30, 2024 −$31.36M
Net Income Q2 2025 · Mar 31, 2024 −$13.75M
Operating Income Q2 2025 · Jun 30, 2025 −$34.93M
Operating Income Q2 2025 · Jun 30, 2025 −$68.1M
Operating Income Q2 2025 · Jun 30, 2024 −$22.2M
Operating Income Q2 2025 · Jun 30, 2024 −$40.05M
Revenue Q2 2025 · Jun 30, 2025 $193K
Revenue Q2 2025 · Jun 30, 2025 $1.36M
Revenue Q2 2025 · Jun 30, 2024 $1.86M
Revenue Q2 2025 · Jun 30, 2024 $2.74M